Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 8.60
+0.60 (7.50%)
Jun 3, 2026, 1:16 PM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 449.14 million as of June 3, 2026. Its market cap has decreased by -29.92% in one year.
Market Cap
449.14M
Enterprise Value
1.02B
Revenue
199.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.60
Market Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 449.14M, a decrease of -58.50%. That is a compound annual growth rate of -14.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 449.14M | -10.10% |
| Dec 31, 2025 | 499.60M | -30.53% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.30B |
| DIVA Laboratories | 1.84B |
| Puriblood Medical | 1.25B |
| Genetics Generation Advancement | 1.08B |
| TFBS Bioscience | 714.51M |
| Kim Forest Enterprise | 712.33M |
| Sofiva Genomics | 710.42M |
| Welgene Biotech | 377.53M |